Improving the Anabolic Action of Plant-based Foods Using Complementary Proteins
CompProtein
2 other identifiers
interventional
11
1 country
1
Brief Summary
In a crossover design 10 young healthy adults (20-35 y) will receive stable isotope tracer infusions and perform a single bout of resistance exercise. Immediately after exercise participants will ingest either 246 g of rice and beans or its constituent macronutrients as isolated amino acids, carbohydrates, fiber, and fat. Repeated blood and muscle biopsies will be collected to determine amino acid concentrations, anabolic signaling and myofibrillar protein synthesis rates during the trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 5, 2024
CompletedFirst Submitted
Initial submission to the registry
October 7, 2024
CompletedFirst Posted
Study publicly available on registry
January 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedMay 8, 2025
May 1, 2025
7 months
October 7, 2024
May 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Myofibrillar protein fractional synthesis rate
Myofibrillar protein synthesis rates will be assessed during the postabsorptive and postprandial periods of experimental primed-constant stable isotope infusions.
Basal FSR (from -150 to - 30 min), Postprandial FSR (from -30 to 300min)
Plasma Amino Acid Concentrations
Amino acid concentrations will be assessed in the postabsorptive state (-210, -150, -90, -30, 0 min) and postprandial state (30, 60, 90, 120, 180, 240, 300 min) via LC/MS/MS.
Post absorptive (-210, -150, -90, -30, 0 min); Post prandial (30, 60, 90, 120, 180, 240, 300 min)
Secondary Outcomes (1)
Activation of Anabolic Signaling Targets
-150 min, -30 min, 300 min
Study Arms (2)
Rice and Beans (COMP)
EXPERIMENTALRice and Beans After resistance exercise, participants will ingest a meal of 123g Rice, 123g Black Beans (246 g; 575kcal, 20 g Protein, 121 g Carbohydrate, 0.7 g Fat, 1.78 g Fat)
Isolated Nutrients (ISO)
ACTIVE COMPARATORThis condition is isonitrogenous and a similar nutrient profile to the experimental complementary mixed meal. The drink is comprised of crystalline amino acids, carbohydrate, fat, and fiber that is matched to rice and beans meal composition.
Interventions
Participants will perform leg press and leg extension immediately prior to ingestion of rice and beans or isolated mixture.
Participants will ingest isolated mixture of crystalized amino acids, maltodextrin, fiber and oil immediately after resistance exercise.
Participants will ingest cooked rice and beans meal immediately after resistance exercise.
Eligibility Criteria
You may qualify if:
- Age 20-35 yrs
- Pre-menopausal
- Recreationally-active
- Weight stable for prior 6 months
You may not qualify if:
- Age outside of range (20 - 35 yrs)
- Pregnancy
- Irregular menstrual cycles (i.e., \~21 day or \~35 day cycle)
- Participation in previous research using \[13C6\]phenylalanine
- Participation in other ongoing research that interferes with this study (e.g., conflicting diet, activity interventions, etc.)
- Any hospitalization or surgery for a metabolic, cardiovascular, or neuromusculoskeletal complication within the past year
- Allergy or hypersensitivity to local anesthetics, latex, or adhesives (bandages, medical tape, etc.)
- Excess scarring after injury
- History of excess bleeding after cut
- Chronic or frequent dizziness/fainting, and arm or leg weakness/numbness
- Arthritis
- Tumors
- Mental Illness
- Hepatorenal, cardiovascular musculoskeletal, autoimmune, or neurological disease or disorder
- Predisposition to hypertrophic scarring or keloid formation
- +12 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Louise Freer Hall
Urbana, Illinois, 61801, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 7, 2024
First Posted
January 17, 2025
Study Start
September 5, 2024
Primary Completion
April 1, 2025
Study Completion
April 1, 2025
Last Updated
May 8, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
Because it is not planned to published in any ICMJE journal.